Sweden: Gabriela Godaly takes on temporary CFO role at SelectImmune Pharma

SelectImmune Pharma, a pharmaceutical company developing new immunotherapies that act as immune enhancers and offer alternatives to antibiotics, has appointed Gabriela Godaly as acting CEO until a new permanent CEO has been appointed. The move comes after the company’s chief executive Ann Gidner last month accepted an offer from a non-competing Life-Science company. Godaly is…

You must be a HMI Subscriber to view this content.

Subscribe Now »